Charles Sermon
Vermögen: 75 138 $ am 31.07.2026
Vermögen: 75 138 $ am 31.07.2026
Charles Edward Sermon is the founder of Mereo BioPharma Group Plc, founded in 2015, holding the title of Secretary, General Counsel & Business Development.
Current jobs include Director at Mereo BioPharma 3 Ltd., Director at Mereo BioPharma 2 Ltd. since 2015, Director at Mereo BioPharma 4 Ltd. since 2017, and Trustee at Rainbow Trust Children's Charity.
Former jobs include Partner at Phase4 Partners Ltd. from 2000 to 2022, Member-Digital, Creative & Science at London Enterprise Panel from 2013 to 2016, and a position at Freshfields in 2004.
Education includes graduation from The University of Hull.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.03.2026 | 1 095 309 ( 0,14 % ) | 75 138 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Gründer | 01.03.2015 |
Mereo Biopharma 3 Ltd.
Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products | Direktor/Vorstandsmitglied | - |
Mereo BioPharma 2 Ltd.
Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology | Direktor/Vorstandsmitglied | 30.06.2015 |
Mereo BioPharma 4 Ltd.
Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Direktor/Vorstandsmitglied | 24.10.2017 |
Rainbow Trust Children's Charity
Rainbow Trust Children's Charity Miscellaneous Commercial ServicesCommercial Services Provides emotional and practical support services | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Phase4 Partners Ltd.
Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Mitglied des Investmentausschusses | 28.02.2022 |
London Enterprise Panel | Corporate Officer/Principal | 01.01.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Phase4 Partners Ltd.
Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
The University of Hull
The University of Hull Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rainbow Trust Children's Charity
Rainbow Trust Children's Charity Miscellaneous Commercial ServicesCommercial Services Provides emotional and practical support services | Commercial Services |
Mereo BioPharma Group Plc
Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
London Enterprise Panel | |
Mereo Biopharma 3 Ltd.
Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products | Health Technology |
Mereo BioPharma 2 Ltd.
Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology | Commercial Services |
Mereo BioPharma 4 Ltd.
Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen